Tamás Koncz
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research, Systemic Lupus Erythematosus Research, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis(2012)931 cited
- → Tofacitinib versus Methotrexate in Rheumatoid Arthritis(2014)765 cited
- → Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial(2013)715 cited
- → Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis(2013)445 cited
- → Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia(2021)440 cited
- → Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations(2007)101 cited
- → Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors(2011)90 cited
- → Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis(2016)78 cited
- → Adherence to biologic DMARD therapies in rheumatoid arthritis(2010)65 cited
- → Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial(2016)57 cited